Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Patients with diagnosis of clinically significant diabetic macular edema, confirmed by fluorangiography and OCT, undergoing to intravitreal dexamethazone injection will be enrolled in the study. Enrollment will take place according to the inclusion/exclusion criteria set by the protocol. The enrolled patients will be randomized for the addition or not of the curcumin formulation (2 tablets/die for 6 months) to intravitreal therapy.
Epistemonikos ID: c085b8b0eff5620c0925a7b8a3b51ec71971404b
First added on: May 21, 2024